Non-Necrotizing Acute Dermohypodermal Infections in Cirrhotic Patients Being Evaluated for Liver Transplantation
Open Access
- 3 February 2025
- journal article
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 28 (1)
Abstract
Introduction: Infections in cirrhotic patients have a significant impact on morbidity and mortality, but little is known about acute non-necrotizing dermohypodermal infections (erysipelas and infectious cellulitis) in this population. The high mortality in this group also represents a loss of opportunity for liver transplantation, which could be a potential solution for these patients. Objectives: This study aims to describe the clinical characteristics, evolution, and outcomes of cirrhotic patients with acute non-necrotizing dermohypodermal infections under evaluation for liver transplant. Methods: A retrospective study was conducted on patients hospitalized with cirrhosis and dermohypodermal infections from 2010 to 2012. Results: Among 983 patients with liver cirrhosis, leading to 2,046 consultations for decompensated cirrhosis, dermohypodermal infections were identified in 65 (7%) cases. The mean age was 58 years (± 10), with 82% male. Cellulitis predominantly affected the lower limbs (70%), followed by the trunk (21%) and upper limbs (9%). Alcoholic liver disease was the primary etiology (56%), followed by alcohol and hepatitis C (17%), isolated hepatitis C (13%), non-alcoholic steatohepatitis (9%), and hepatitis B (3%). Based on the Child-Pugh score, 8% were classified as class A, 46% as class B, and 46% as class C. The average model for end-stage liver disease (MELD) score was 20 (± 8). Commonly associated infections included urinary tract infection (54%), pneumonia (25%), and spontaneous bacterial peritonitis (21%). Prescribed antibiotics were clindamycin (71%), cephalosporins (40%), oxacillin (18%), penicillin (11%), vancomycin (11%), quinolones (4.5%), and other antibiotics (15.3%). Sepsis occurred in 14% of cases, and the mortality rate was 18.5% (n=12). Among the deceased patients, 67% (n=8) had concomitant infections with cellulitis. Factors significantly associated with mortality were concomitant infections (69 vs. 31%, p = 0.02) and elevated C-reactive protein levels (6 vs. 3 mg/dL, p = 0.03). Conclusion: This study highlights the high hospital mortality rate among cirrhotic patients with acute non-necrotizing dermohypodermal infections, especially when concomitant infections are present. The high mortality not only reflects the severity of the condition but also represents a loss of opportunity for potentially life-saving interventions, such as liver transplantation. Further research is needed to improve the management of cirrhotic patients with dermohypodermal infections.Keywords
This publication has 17 references indexed in Scilit:
- Assessment of Antibiotic Treatment of Cellulitis and ErysipelasJAMA Dermatology, 2019
- Prophylactic Antibiotics to Prevent Cellulitis of the Leg: Economic Analysis of the PATCH I & II TrialsPLOS ONE, 2014
- The impact of bacterial infections on survival of patients with decompensated cirrhosisAnnals of Hepatology, 2014
- Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective studyHepatology, 2011
- Epidemiological Data and Comorbidities of 428 Patients Hospitalized With ErysipelasAngiology, 2010
- Management of Adult Patients with Ascites Due to CirrhosisHepatology, 2009
- Risk factors for bacteremia in patients with limb cellulitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue InfectionsClinical Infectious Diseases, 2005
- Erysipelas: Clinical and Bacteriologic Spectrum and Serological AspectsClinical Infectious Diseases, 1996
- A prospective study of bacterial infections in patients with cirrhosisJournal of Hepatology, 1993